1
|
Roever L, Tse G, Biondi-Zoccai G. Walking or cycling to work to prevent myocardial infarction: Hope or hype? Eur J Prev Cardiol 2019; 27:820-821. [PMID: 31610711 DOI: 10.1177/2047487319880365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Leonardo Roever
- Department of Clinical Research, Federal University of Uberlândia, Brazil
| | - Gary Tse
- Xiamen Cardiovascular Hospital, P. R. China.,Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Second Hospital of Tianjin Medical University, P. R. China.,The First Affiliated Hospital of Dalian Medical University, P. R. China
| | - Giuseppe Biondi-Zoccai
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy.,Mediterranea Cardiocentro, Italy
| |
Collapse
|
2
|
Roever L, Tse G, Biondi-Zoccai G. Variability of metabolic parameters and risk of heart failure: Can it be a marker of incident heart failure? Int J Cardiol 2019; 293:183-184. [PMID: 31296395 DOI: 10.1016/j.ijcard.2019.07.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Accepted: 07/02/2019] [Indexed: 02/05/2023]
Affiliation(s)
- Leonardo Roever
- Federal University of Uberlândia, Department of Clinical Research, Brazil.
| | - Gary Tse
- Shenzhen Research Institute, The Chinese University of Hong Kong, China
| | - Giuseppe Biondi-Zoccai
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Mediterranea Cardiocentro, Napoli, Italy
| |
Collapse
|
3
|
Non-HDL-c/TC: A Novel Lipid-Related Marker in the Assessment of Severity of Coronary Artery Lesions and Cardiovascular Outcomes. Cardiol Res Pract 2019; 2019:5931975. [PMID: 31179126 PMCID: PMC6507170 DOI: 10.1155/2019/5931975] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2018] [Revised: 02/16/2019] [Accepted: 03/17/2019] [Indexed: 01/14/2023] Open
Abstract
Background Non-high-density lipoprotein cholesterol (non-HDL-c) predicts the severity of coronary artery lesions in patients not treated with statin. The association between non-HDL-c and severity of coronary artery lesions in patients treated with lipid-lowering therapy has been unknown. Hypothesis We hypothesize a novel marker of non-HDL-c/TC predicts the severity of coronary artery lesions and clinical outcomes in 12 months in the patients treated with statin. Method 473 subjects who met inclusion criteria were eligible for inclusion. Coronary artery angiography (CAG) was performed, and the Gensini score (GS) was calculated in all the subjects divided into three subgroups of low risk, medium risk, and high risk by the tertiles of GS. The non-HDL-c value was calculated as TC minus HDL-c, while non-HDL-c/TC was the ratio of non-HDL-c and TC. Results The concentration of non-LDL-c differed between non-obstructive-CAD group and obstructive-CAD group (P < 0.05), and non-HDL-c/TC was elevated in the obstructive-CAD group (P < 0.05). Increased GS was associated with increasing non-HDL-c/TC (P < 0.05). Non-HDL-c/TC (OR: 108.50, 95% CI: 1.57–7520.28; P=0.030) remained as an independent predicting factor of high risk under GS stratification. In unadjusted Cox model, high non-HDL-c/TC (RR: 1.976, 95% CI: 1.155–3.382; P=0.013) predicted the occurrence of adverse events. After multivariate adjustment, high non-HDL-c/TC (RR: 1.921, 95% CI: 1.105–3.339; P=0.021) was an independent predictor of poor outcomes. Conclusion High level of non-HDL-c/TC presented an excellent prognostic value compared with other lipid-related markers in CAD patients treated with statin.
Collapse
|
4
|
Roever L, Tse G, Biondi-Zoccai G. Improvement of LDL cholesterol target achievement rates through cardiac rehabilitation after myocardial infarction. Eur J Prev Cardiol 2019; 26:791-792. [PMID: 30665315 DOI: 10.1177/2047487319825511] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Leonardo Roever
- Department of Clinical Research, Federal University of Uberlândia, Brazil
| | - Gary Tse
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, China
| | - Giuseppe Biondi-Zoccai
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy
- IRCCS Neuromed, Italy
| |
Collapse
|
5
|
Roever L, Resende ES, Diniz ALD, Penha-Silva N, O’Connell JL, Gomes PFS, Zanetti HR, Roerver-Borges AS, Veloso FC, de Souza FR, Duarte PRA, Fidale TM, Casella-Filho A, Dourado PMM, Chagas ACP, Ali-Hasan-Al-Saegh S, Reis PEO, Pinto RDMC, Oliveira GB, Avezum Á, Neto M, Durães AR, da Silva RMFL, Grande AJ, Denardi C, Lopes RD, Nerlekar N, Alizadeh S, Hernandez AV, da Rosa MI, Biondi-Zoccai G. High-density lipoprotein-cholesterol functionality and metabolic syndrome: Protocol for review and meta-analysis. Medicine (Baltimore) 2018; 97:e11094. [PMID: 29901625 PMCID: PMC6023647 DOI: 10.1097/md.0000000000011094] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/07/2018] [Accepted: 05/23/2018] [Indexed: 02/05/2023] Open
Abstract
INTRODUCTION The prevalence of metabolic syndrome (MetS) and MetS-related stroke is set to increase dramatically in coming decades. MetS is a complex disease that includes endothelial dysfunction, insulin resistance, diabetes, hypertension, ectopic obesity, and dyslipidaemia and an increased risk of cardiovascular events. One function of high-density lipoprotein (HDL) cholesterol (HDL-C) is the cholesterol-efflux pathway, which is the pathway where cholesterol is removed from macrophages within the arterial walls back into the bloodstream and out to the liver. As one of the key functions of HDL, their hypothesis was that if they could measure HDL-C-efflux capacity, they would have a better handle on the role of HDL in atherosclerosis. However, there are no systematic analyses or well-conducted meta-analyses to evaluate the relationship between HDL-C functionality and MetS. The aim of this study is to examine this association of HDL-C functionality with MetS in different ages and sex. METHODS AND ANALYSIS The update systematic review and meta-analysis will be conducted using published studies that will be identified from electronic databases (i.e., PubMed, EMBASE, Web of Science, and Google Scholar). Studies that examined the association between HDL-C functionality and MetS; focused on cohort, case-control, and cross-sectional studies; were conducted among in adults aged 40 to 70 years; provided sufficient data for calculating odds ratio or relative risk with a 95% confidence interval; were published as original articles written in English or other languages; and have been published until January 2018 will be included. Study selection, data collection, quality assessment, and statistical syntheses will be conducted based on discussions among investigators. ETHICS AND DISSEMINATION Ethics approval was not required for this study because it was based on published studies. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. TRIAL REGISTRATION NUMBER PROSPERO (CRD42018083465).
Collapse
Affiliation(s)
- Leonardo Roever
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Elmiro Santos Resende
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Angélica Lemos Debs Diniz
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Nilson Penha-Silva
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - João Lucas O’Connell
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Paulo Fernando Silva Gomes
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Hugo Ribeiro Zanetti
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
- Department of Clinical Research, HCFMUSP- University of São Paulo Medical School, Department of Cardiology, São Paulo
| | - Anaisa Silva Roerver-Borges
- Department of Clinical Research, HCFMUSP- University of São Paulo Medical School, Department of Cardiology, São Paulo
| | - Fernando César Veloso
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Fernanda Rodrigues de Souza
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Poliana Rodrigues Alves Duarte
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Thiago Montes Fidale
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | | | | | - Antonio Carlos Palandri Chagas
- Department of Cardiology, Faculty of Medicine ABC, Santo André, Brazil
- Department of Cardiology, Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
| | | | | | - Rogério de Melo Costa Pinto
- Federal University of Uberlândia, Department of Clinical Research, Heart Institute (InCor), Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Gustavo B.F. Oliveira
- Department of Health and Sciences, Graduate Program in Medicine and Health, Federal University of Bahia, Bahia
| | - Álvaro Avezum
- Department of Health and Sciences, Graduate Program in Medicine and Health, Federal University of Bahia, Bahia
| | - Mansueto Neto
- Department of Cardiology, Federal University of Minas Gerais, MG
| | | | | | | | - Celise Denardi
- Department of Clinical Research, Division of Cardiology, Duke University Medical Center, Durham, NC
| | - Renato Delascio Lopes
- Department of Cardiology, Monash Cardiovascular Research Centre and MonashHeart, Clayton, Victoria, Australia
| | - Nitesh Nerlekar
- Department of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Shahab Alizadeh
- Department of Comparative Effectiveness and Outcomes Research Health Outcomes, University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT
| | - Adrian V. Hernandez
- Laboratory of Epidemiology, University of Extremo Sul Catarinense, Criciúma, Brazil
| | - Maria Inês da Rosa
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina
| | | |
Collapse
|
6
|
Roever L, Tse G, Biondi-Zoccai G. Trends in cardiovascular disease in Australia and in the world. Eur J Prev Cardiol 2018; 25:1278-1279. [PMID: 29808763 DOI: 10.1177/2047487318778339] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Leonardo Roever
- 1 Federal University of Uberlândia, Department of Clinical Research, Brazil
| | - Gary Tse
- 2 Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, China.,3 Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, China
| | - Giuseppe Biondi-Zoccai
- 4 Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.,5 Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy
| |
Collapse
|
7
|
Roever L, Resende ES, Diniz ALD, Penha-Silva N, O’Connell JL, Gomes PFS, Zanetti HR, Roerver-Borges AS, Veloso FC, de Souza FR, Duarte PRA, Fidale TM, Casella-Filho A, Dourado PMM, Chagas ACP, Ali-Hasan-Al-Saegh S, Reis PEO, Pinto RDMC, Oliveira GBF, Avezum Á, Neto M, Durães A, da Silva RMFL, Grande AJ, Denardi C, Lopes RD, Nerlekar N, Alizadeh S, Hernandez AV, da Rosa MI, Biondi-Zoccai G. Epicardial adipose tissue and metabolic syndrome: An update protocol for systematic review and meta-analysis. Medicine (Baltimore) 2018; 97:e0387. [PMID: 29668593 PMCID: PMC5916668 DOI: 10.1097/md.0000000000010387] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/05/2018] [Accepted: 03/21/2018] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND The prevalence of metabolic syndrome (MetS) and MetS-related stroke is set to increase dramatically in coming decades. MetS is a complex disease that includes endothelial dysfunction, insulin resistance, diabetes, hypertension, ectopic obesity, and dyslipidaemia, and an increased risk of cardiovascular events. However, there are no systematic analyses, or well-conducted meta-analyses to evaluate the relationship between epicardial adipose tissue (EAT) and (MetS). The aim of this study is to examine this association of EAT with MetS in different ages and sex. METHODS The update systematic review, and meta-analysis will be conducted using published studies that will be identified from electronic databases (ie, PubMed, EMBASE, Web of Science, and Google Scholar. Studies that firstly, examined the association between EAT and MetS, secondly, focus on cohort, case-control, and cross-sectional studies, thirdly, were conducted among in adults aged between 40 and 70 years, fourth, provided sufficient data for calculating ORs or relative risk with a 95% CI, fifth, were published as original articles written in English or other languages, and sixth, have been published until January year 2018 will be included. Study selection, data collection, quality assessment, and statistical syntheses will be conducted based on discussions among investigators. RESULTS Ethics approval was not required for this study because it was based on published studies. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. This study will provide a high quality synthesis on the association of EAT and MetS. CONCLUSION This systematic review will provide evidence to assess whether there is a strong association of EAT and MetS, and its components.
Collapse
Affiliation(s)
- Leonardo Roever
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Elmiro Santos Resende
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Angélica Lemos Debs Diniz
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Nilson Penha-Silva
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - João Lucas O’Connell
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Paulo Fernando Silva Gomes
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Hugo Ribeiro Zanetti
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
- Department of Clinical Research, HCFMUSP - University of São Paulo Medical School, Department of Cardiology
| | | | - Fernando César Veloso
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Fernanda Rodrigues de Souza
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Poliana Rodrigues Alves Duarte
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Thiago Montes Fidale
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | | | | | - Antonio Carlos Palandri Chagas
- Faculty of Medicine ABC, Department of Cardiology Santo André
- Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Department of Cardiology, Yazd, Iran
| | | | | | - Rogério de Melo Costa Pinto
- Federal University of Uberlândia, Department of Clinical Research, Master Institute of Education President Antonio Carlos, IMEPAC, Araguari
| | - Gustavo B. F. Oliveira
- Graduate Program in Medicine and Health, Department of Health and Sciences, Federal University of Bahia
| | - Álvaro Avezum
- Graduate Program in Medicine and Health, Department of Health and Sciences, Federal University of Bahia
| | - Mansueto Neto
- Federal University of Minas Gerais, Department of Cardiology, MG
| | - André Durães
- Federal University of Minas Gerais, Department of Cardiology, MG
| | | | | | - Celise Denardi
- Division of Cardiology, Duke University Medical Center, Department of Clinical Research, Durham, NC
| | - Renato Delascio Lopes
- Monash Cardiovascular Research Centre and MonashHeart, Department of Cardiology, Clayton, Victoria, Australia
| | - Nitesh Nerlekar
- Department of Medicine, Tehran University of Medical Sciences
| | - Shahab Alizadeh
- University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, Department of Comparative Effectiveness and Outcomes Research Health Outcomes, CT
| | - Adrian V. Hernandez
- Laboratory of Epidemiology, University of Extremo Sul Catarinense, Criciúma, Brazil
| | - Maria Inês da Rosa
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina
| | | |
Collapse
|
8
|
Roever L, Resende ES, Diniz ALD, Penha-Silva N, O’Connell JL, Gomes PFS, Zanetti HR, Roerver-Borges AS, Veloso FC, Fidale TM, Casella-Filho A, Dourado PMM, Chagas ACP, Ali-Hasan-Al-Saegh S, Reis PEO, Pinto RDM, Oliveira GB, Avezum Á, Neto M, Durães A, da Silva RMFL, Grande AJ, Denardi C, Lopes RD, Nerlekar N, Alizadeh S, Hernandez AV, Biondi-Zoccai G. Metabolic syndrome and risk of stroke: Protocol for an update systematic review and meta-analysis. Medicine (Baltimore) 2018; 97:e9862. [PMID: 29642227 PMCID: PMC5908602 DOI: 10.1097/md.0000000000009862] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/22/2018] [Accepted: 01/23/2018] [Indexed: 02/07/2023] Open
Abstract
INTRODUCTION The metabolic syndrome is composed of several cardiovascular risk factors and has a high prevalence throughout the world. However, there are no systematic analyses or well-conducted meta-analyses to evaluate the relationship between metabolic syndrome and stroke. The aim of this study is to examine this association of metabolic syndrome with stroke in different ages and sex. METHODS AND ANALYSIS The update systematic review and meta-analysis will be conducted using published studies that will be identified from electronic databases (i.e., PubMed, EMBASE, Web of Science, and Google Scholar. Studies that examined the association between metabolic syndrome and stroke, had a longitudinal or prospective cohort design, were conducted among in adults aged 40 to 70 years, provided sufficient data for calculating ORs or relative risk with a 95% CI, were published as original articles written in English or other languages, and have been published until December 2017 will be included. Study selection, data collection, quality assessment, and statistical syntheses will be conducted based on discussions among investigators. ETHICS AND DISSEMINATION Ethics approval was not required for this study because it was based on published studies. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. The findings from this study could be useful for assessing metabolic syndrome risk factors in stroke, and determining approaches for prevention of stroke in the future.
Collapse
Affiliation(s)
- Leonardo Roever
- Federal University of Uberlândia, Department of Clinical Research
| | | | | | | | | | | | - Hugo Ribeiro Zanetti
- Federal University of Uberlândia, Department of Clinical Research
- Heart Institute (InCor), Master Institute of Education President Antonio Carlos, Department of Clinical Research, IMEPAC, Araguari, Brazil
| | | | | | | | | | | | - Antonio Carlos Palandri Chagas
- HCFMUSP—University of São Paulo Medical School, Department of Cardiology, São Paulo
- Faculty of Medicine ABC, Department of Cardiology Santo André, Brazil
| | - Sadeq Ali-Hasan-Al-Saegh
- Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Department of Cardiology, Yazd, Iran
| | - Paulo Eduardo Ocke Reis
- Department of Specialized and General Surgery, Fluminense Federal University, Rio de Janeiro
| | | | - Gustavo B.F. Oliveira
- Dante Pazzanese Institute of Cardiology, São Paulo, Brazil; Dante Pazzanese Institute of Cardiology, Department of Clinical Research São Paulo
| | - Álvaro Avezum
- Dante Pazzanese Institute of Cardiology, São Paulo, Brazil; Dante Pazzanese Institute of Cardiology, Department of Clinical Research São Paulo
| | - Mansueto Neto
- Graduate Program in Medicine and Health, Department of Heath and Sciences, Federal University of Bahia
| | - André Durães
- Graduate Program in Medicine and Health, Department of Heath and Sciences, Federal University of Bahia
| | | | | | | | - Renato Delascio Lopes
- Division of Cardiology, Duke University Medical Center, Department of Clinical Research, Durham, NC
| | - Nitesh Nerlekar
- Monash Cardiovascular Research Centre and Monash Heart, Department of Cardiology, Clayton, Victoria, Australia
| | - Shahab Alizadeh
- Tehran University of Medical Sciences, Department of Medicine, Iran
| | - Adrian V. Hernandez
- University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, Department of Comparative Effectiveness and Outcomes Research Health Outcomes, CT
| | - Giuseppe Biondi-Zoccai
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy Department of Angiocardioneurology, IRCCS Neuromed, Pozzilli, Italy
| |
Collapse
|
9
|
Roever L, Resende ES, Diniz ALD, Penha-Silva N, O’Connell JL, Gomes PFS, Zanetti HR, Roerver-Borges AS, Veloso FC, de Souza FR, Duarte PRA, Fidale TM, Casella-Filho A, Dourado PMM, Chagas ACP, Ali-Hasan-Al-Saegh S, Reis PEO, Pinto RDMC, Oliveira GBF, Avezum Á, Neto M, Durães A, da Silva RMFL, Grande AJ, Denardi C, Lopes RD, Nerlekar N, Alizadeh S, Hernandez AV, da Rosa MI, Biondi-Zoccai G. Epicardial adipose tissue and carotid artery disease: Protocol for systematic review and meta-analysis. Medicine (Baltimore) 2018; 97:e0273. [PMID: 29702973 PMCID: PMC5944522 DOI: 10.1097/md.0000000000010273] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/05/2018] [Accepted: 03/08/2018] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Atherosclerosis is now widely recognized as a multifactorial disease with outcomes that arise from complex factors such as plaque components, blood flow, and inflammation. Epicardial adipose tissue (EAT) is a metabolically active fat depot, abundant in proinflammatory cytokines, and has been correlated with the extent and severity of carotid artery disease (CD). The locations most frequently affected by carotid atherosclerosis are the proximal internal carotid artery (ie, the origin) and the common carotid artery bifurcation. Progression of atheromatous plaque at the carotid bifurcation results in luminal narrowing, often accompanied by ulceration. However, there are no systematic analyses or well-conducted meta-analyses to evaluate the relationship between EAT and CD. The aim of this study is to examine this association of EAT with CD in different ages and sex. METHODS This systematic review and meta-analysis will be conducted using published studies that will be identified from electronic databases (ie, PubMed, EMBASE, Web of Science, and Google Scholar. Studies that (1) examined the association between EAT and CD, (2) focus on cohort, case-control and cross-sectional studies, (3) will conducted among in adults aged 40 to 70 years, (4) provided sufficient data for calculating ORs or relative risk with a 95% CI, (5) will published as original articles written in English or other languages, and (6) have been published until January 2018 will be included. Study selection, data collection, quality assessment and statistical syntheses will be conducted based on discussions among investigators. RESULTS We propose the current protocol to evaluate the evaluation of EAT with ED. CONCLUSION This systematic review will not need ethical approval, because it does not involve human beings. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. ETHICS AND DISSEMINATION Ethics approval was not required for this study because it was based on published studies. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. TRIAL REGISTRATION NUMBER PROSPERO (CRD42018083458).
Collapse
Affiliation(s)
- Leonardo Roever
- Federal University of Uberlândia, Department of Clinical Research
| | | | | | | | | | | | - Hugo Ribeiro Zanetti
- Federal University of Uberlândia, Department of Clinical Research
- Heart Institute (InCor), Master Institute of Education President Antonio Carlos, Department of Clinical Research, IMEPAC, Araguari
| | - Anaisa Silva Roerver-Borges
- Heart Institute (InCor), Master Institute of Education President Antonio Carlos, Department of Clinical Research, IMEPAC, Araguari
| | | | | | | | | | | | | | - Antonio Carlos Palandri Chagas
- HCFMUSP—University of São Paulo Medical School, Department of Cardiology, São Paulo
- Faculty of Medicine ABC, Department of Cardiology Santo André, Brazil
| | - Sadeq Ali-Hasan-Al-Saegh
- Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Department of Cardiology, Yazd, Iran
| | - Paulo Eduardo Ocke Reis
- Department of Specialized and General Surgery, Fluminense Federal University, Rio de Janeiro
| | | | - Gustavo B. F. Oliveira
- Dante Pazzanese Institute of Cardiology, Department of Clinical Research, São Paulo, Brazil
| | - Álvaro Avezum
- Dante Pazzanese Institute of Cardiology, Department of Clinical Research, São Paulo, Brazil
| | - Mansueto Neto
- Graduate Program in Medicine and Health, Department of Health and Sciences, Federal University of Bahia
| | - André Durães
- Graduate Program in Medicine and Health, Department of Health and Sciences, Federal University of Bahia
| | | | | | - Celise Denardi
- FOP Unicamp, Department of Clinical Research, SP, Brazil
| | - Renato Delascio Lopes
- Division of Cardiology, Duke University Medical Center, Department of Clinical Research, Durham, NC
| | - Nitesh Nerlekar
- Monash Cardiovascular Research Centre and MonashHeart, Department of Cardiology, Clayton, Victoria, Australia
| | - Shahab Alizadeh
- Tehran University of Medical Sciences, Department of Medicine
| | - Adrian V. Hernandez
- University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, Department of Comparative Effectiveness and Outcomes Research Health Outcomes, CT
| | - Maria Inês da Rosa
- Laboratory of Epidemiology, University of Extremo Sul Catarinense, Criciúma, Brazil
| | - Giuseppe Biondi-Zoccai
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy
| |
Collapse
|
10
|
Sun D, Zhang L, Chen H, Feng R, Cao P, Liu Y. Effects of Antarctic krill oil on lipid and glucose metabolism in C57BL/6J mice fed with high fat diet. Lipids Health Dis 2017; 16:218. [PMID: 29157255 PMCID: PMC5697064 DOI: 10.1186/s12944-017-0601-8] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Accepted: 10/30/2017] [Indexed: 12/04/2022] Open
Abstract
Background Obesity and other metabolic diseases have become epidemic which greatly affect human health. Diets with healthy nutrition are efficient means to prevent this epidemic occurrence. Novel food resources and process technology were needed for these purpose. In this study, Antarctic krill oil (KO) extracted from a dry krill by a procedure of hot pump dehydration in combined with freezing-drying was used to investigate health effect in animals including the growth, lipid and glucose metabolism. Methods C57BL/6J mice were fed with a lard based high fat (HF) diet and substituted with KO for a period of 12 weeks in comparison with low fat normal control (NC) diet. Mice body weight and food consumption were recorded. Serum lipid metabolism - of C57BL/6J mice serum was measured. A glucose tolerance tests (GTTs) and pathology analysis of mice were performed at the end of the experiment. Results The KO fed mice had less body weight gain, less fat accumulation in tissue such as adipose and liver. Dyslipidemia induced by high fat diet was partially improved by KO feeding with significant reduction of serum low density lipoprotein-cholesterol (LDL-C) content. Furthermore, KO feeding also improved glucose metabolism in C57BL/6J mice including a glucose tolerance of about 22% vs. 32% of AUC (area under the curve) for KO vs HF diet and the fast blood glucose level of 8.5 mmol/L, 9.8 mmol/L and 9.3 mmol/L for NC, HF and KO diet groups, respectively. In addition, KO feeding also reduced oxidative damage in liver with a decrease of malondialdehyde (MDA) content and increase of superoxide dismutase (SOD) content. Conclusion This study provided evidence of the beneficial effects of KO on animal health from the processed technology, particularly on lipid and glucose metabolism. This study confirmed that as the Antarctic krill was extracted with a procedure of efficient energy, it might make it possible for Krill oil to be available for food industry.
Collapse
Affiliation(s)
- Dewei Sun
- State Key Laboratory of Food Science and Technology, Synergetic Innovation Center of Food Safety and Nutrition, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, People's Republic of China
| | - Liang Zhang
- State Key Laboratory of Food Science and Technology, Synergetic Innovation Center of Food Safety and Nutrition, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, People's Republic of China
| | - Hongjian Chen
- State Key Laboratory of Food Science and Technology, Synergetic Innovation Center of Food Safety and Nutrition, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, People's Republic of China
| | - Rong Feng
- State Key Laboratory of Food Science and Technology, Synergetic Innovation Center of Food Safety and Nutrition, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, People's Republic of China
| | - Peirang Cao
- State Key Laboratory of Food Science and Technology, Synergetic Innovation Center of Food Safety and Nutrition, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, People's Republic of China.
| | - Yuanfa Liu
- State Key Laboratory of Food Science and Technology, Synergetic Innovation Center of Food Safety and Nutrition, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, People's Republic of China.
| |
Collapse
|
11
|
Roever L, Biondi-Zoccai G, Rao SV. Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination? Clin Ther 2017; 39:659-660. [PMID: 28190598 DOI: 10.1016/j.clinthera.2017.01.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2016] [Accepted: 01/22/2017] [Indexed: 02/08/2023]
Abstract
Cardiovascular disease is the leading cause of death in the world. Dyslipidemia, manifested by elevated low-density lipoprotein cholesterol (LDL-C) levels, is central to the development and progression of atherosclerosis. Dyslipidemia has become a primary target of intervention in strategies for the prevention of cardiovascular events. Therapeutic lifestyle changes, such as increased physical activity, weight loss, smoking cessation, and adoption of a healthier diet, are effectively reducing cardiovascular risk in primary and secondary prevention. The combination therapy lowered LDL-C levels and achieved the LDL-C target in patients with high cardiovascular risk.
Collapse
Affiliation(s)
- Leonardo Roever
- Department of Clinical Research, Federal University of Uberlândia, Uberlândia, Brazil.
| | - Giuseppe Biondi-Zoccai
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Department of AngioCardioNeurology, IRCCS Neuromed, Pozzilli, Italy
| | - Sunil V Rao
- Duke Clinical Research Institute, Durham, North Carolina
| |
Collapse
|
12
|
Lipoprotein Subfractions in Type 2 Diabetes. Heart Lung Circ 2016; 26:209-210. [PMID: 28087153 DOI: 10.1016/j.hlc.2016.11.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Accepted: 11/21/2016] [Indexed: 02/06/2023]
|